SCN2A Encephalopathy research hub

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

This study is testing a new medicine, PRAX-562, for children and teenagers aged 1 to 18 who have severe forms of epilepsy called SCN2A or SCN8A encephalopathy. It aims to see if the medicine is safe and if it helps reduce seizures.